Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Challenges Facing Contemporary Pediatric Nephrology: A Call to Global Advocacy.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: October 23, 2025
The Advancing the Development of Pediatric Therapeutics 8 (ADEPT 8) Workshop on Drug Dosing in Pediatric Patients with Renal Impairment.
Journal: The Journal of pediatrics
Published: November 27, 2024
Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials.
Journal: Dermatology and therapy
Published: January 09, 2024
Detection, Monitoring, and Mitigation of Drug-Induced Nephrotoxicity: A Pragmatic Approach.
Journal: Therapeutic innovation & regulatory science
Published: July 28, 2023
Liver injury in cynomolgus monkeys following intravenous and intrathecal scAAV9 gene therapy delivery.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 09, 2023
Physician knowledge, attitudes, and practices regarding physical activity restrictions in pediatric hemodialysis patients.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis
Published: February 23, 2023
Neurofilament light chain and dorsal root ganglia injury after adeno-associated virus 9 gene therapy in nonhuman primates.
Journal: Molecular therapy. Methods & clinical development
Published: September 19, 2022
Review of cardiac safety in onasemnogene abeparvovec gene replacement therapy: translation from preclinical to clinical findings.
Journal: Gene therapy
Published: August 19, 2022
Single-Dose Intrathecal Dorsal Root Ganglia Toxicity of Onasemnogene Abeparvovec in Cynomolgus Monkeys.
Journal: Human gene therapy
Published: March 25, 2022
Safety of Onasemnogene Abeparvovec for Patients With Spinal Muscular Atrophy 8.5 kg or Heavier in a Global Managed Access Program.
Journal: Pediatric neurology
Published: January 06, 2022
Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy.
Journal: Drug safety
Published: December 23, 2021
Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy.
Journal: Drug safety
Published: August 03, 2021
Last Updated: 09/26/2026